Rapid PCR Identifies Bloodstream Pathogens Within 1 Hour in Oncology Patients
Overview
A multiplex PCR assay detected bloodstream pathogens in 94% of positive blood cultures with results available within 1 hour, significantly faster than conventional methods. The assay showed high agreement with standard microbiological techniques and identified antimicrobial resistance genes, potentially enabling earlier targeted therapy in high-risk oncology patients.
Background
Bloodstream infections require prompt identification of causative pathogens to guide effective antimicrobial therapy, especially in immunocompromised oncology patients. Conventional microbiological methods typically take 24 to 48 hours for pathogen identification and susceptibility testing. Rapid molecular diagnostics, such as multiplex PCR panels, offer the potential to accelerate this process. This study evaluated the BioFire FilmArray Blood Culture Identification 2 panel's performance compared to standard methods in a single-center oncology hospital setting.
Data Highlights
| Parameter | Value |
|---|---|
| Positive blood culture bottles tested | 93 |
| Pathogens identified by multiplex PCR | 87 (94%) |
| Microorganisms identified by multiplex PCR | 96 |
| Microorganisms identified by standard methods | 92 |
| Monomicrobial cultures | 85 |
| Polymicrobial cultures | 8 |
| Resistance genes detected | 107 total in 59 bacteria |
| Common resistance genes | CTX-M (49), OXA-48–like (23), NDM (22) |
| Time to result multiplex PCR | ~1 hour |
| Time to result conventional methods | 24–48 hours |
Key Findings
- The multiplex PCR panel identified pathogens in 94% of positive blood cultures, demonstrating high concordance with standard microbiological methods.
- The assay detected 96 microorganisms compared to 92 identified by conventional methods, including all organisms in polymicrobial samples.
- Gram-negative bacteria predominated, with Klebsiella pneumoniae (43 isolates) and Escherichia coli (24 isolates) most common.
- The panel detected 107 antimicrobial resistance genes across 59 bacterial isolates, primarily CTX-M, OXA-48–like, and New Delhi metallo-beta-lactamase genes.
- Phenotypic susceptibility testing generally correlated with resistance gene detection, with one exception of a K pneumoniae strain carrying OXA-48 remaining meropenem susceptible.
- Main limitation was inability to detect organisms not included in the assay, and the study was limited by single-center design and sample size.
Clinical Implications
The rapid turnaround time of approximately 1 hour for pathogen and resistance gene identification can facilitate earlier targeted antimicrobial therapy in high-risk oncology patients with bloodstream infections. This may improve clinical outcomes by reducing delays inherent in conventional culture-based methods. However, clinicians should be aware of the assay's limitations in detecting organisms outside its panel and consider complementary testing as needed.
Conclusion
The BioFire FilmArray Blood Culture Identification 2 panel offers a rapid, reliable method for identifying bloodstream pathogens and resistance genes, supporting timely and precise antimicrobial management in oncology patients. Further studies are warranted to validate these findings in broader clinical settings.
References
- Mumcuoğlu et al. 2024 -- Rapid PCR Detects Bloodstream Pathogens in 1 Hour
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
